Speaker Profile

Ph.D., Director, Product Innovation & Strategic Commercialization, The Jackson Laboratory

Dr. Mockus is the Director of Product Innovation & Strategic Commercialization at The Jackson Laboratory for Genomic Medicine, where she leads a team disrupting the status quo for interpreting biomedical data. Under her vision and leadership, the organization’s first software product, JAX-CKB, was commercialized. JAX-CKB is a cancer bioinformatics platform used by translational researchers, diagnostic labs, and oncologists across the globe. Her primary focus is on the capture, analysis, and utilization of big-data with AI to disrupt how knowledge is translated from the bench to the bedside. She has over 15-years of industry experience in business development and product innovation.

Genomic Profiling Showcase:
Jackson Laboratory

The Jackson Laboratory is an independent, nonprofit biomedical research institution dedicated to contributing to a future of better health care based on the unique genetic makeup of each individual.

Accelerating Interpretation Of Precision Oncology Data With Machine Reading
Implementation of precision oncology requires scalable interpretative tools that address the growing complexity of genetic/genomic data and corresponding treatment modalities. The Clinical Knowledgebase (CKB) leverages Microsoft’s Hanover AI machine-reading technology to provide computer-assisted human curation at scale.

 Session Abstract – PMWC 2020 Silicon Valley

The PMWC 2020 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.